Article ID Journal Published Year Pages File Type
107980 Toxicologie Analytique et Clinique 2015 4 Pages PDF
Abstract
Brimonidine is a selective alpha-2-adrenergic agonist used to treat glaucoma. We report a case of a 9-day-old female who developed, 90 minutes after accidental ingestion of 3 eye drops of 0.2% brimonidine, coma, apnea, hyperglycemia and miosis requiring intubation and mechanical ventilation. Plasma concentration, 3 hours after intake, was 11.7 ng/mL. Normal consciousness was reached after 27 hours. Apnea recovered slowly, normal breath was reached 47 hours after accidental intake. This report adds to the existing evidence that brimonidine has serious systemic effects in newborns and can require fast and supportive management in intensive care unit.
Related Topics
Health Sciences Medicine and Dentistry Forensic Medicine
Authors
, , , , , , , , , , , ,